"
Team:Waterloo
From 2014.igem.org
(Difference between revisions)
m |
m |
||
| Line 31: | Line 31: | ||
</div> | </div> | ||
<!-- here go the centered images --> | <!-- here go the centered images --> | ||
| - | <h2 class="centerUpper blueOnGrey" style="margin: | + | <h2 class="centerUpper blueOnGrey" style="margin-left: 2%; margin-right: 2%; margin-top: 80;"">Project Cornerstones</h2> |
<div style="padding:20px 20px; text-align:center; width:100%; margin: auto;" > | <div style="padding:20px 20px; text-align:center; width:100%; margin: auto;" > | ||
<a href="https://2014.igem.org/Team:Waterloo/Deliver"><img src="https://static.igem.org/mediawiki/2014/9/98/Waterloo_deliver_icon.png" class="icon" /></a> | <a href="https://2014.igem.org/Team:Waterloo/Deliver"><img src="https://static.igem.org/mediawiki/2014/9/98/Waterloo_deliver_icon.png" class="icon" /></a> | ||
Revision as of 23:44, 17 October 2014
Staphylocide
Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation
Problem
MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...
Solution
...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.
Project Cornerstones
Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.
